Ray J. Lin

Ray Lin practices at Emanate Health Inter-Community Hospital in Covina, California, part of Emanate Health.

Ray Lin's NPI, 1649693540, was assigned on January 28, 2014. Ray Lin holds California license 51415.

Ray Lin's primary practice is Emanate Health Inter-Community Hospital, at 210 W San Bernardino Road, Covina, CA 91723 in Los Angeles County. The practice phone is (626) 814-2468.

Ray Lin's primary practice is Emanate Health Inter-Community Hospital in Covina, California, part of Emanate Health. The medical group on file is Island Dermatology. Dmand AI also links Ray Lin to 1 more behavioral health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ray Lin practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is Ray Lin's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Ray Lin is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Ray Lin's licenses on file in 2 states: California and Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, itchy rashes, minor injury to a limb and psoriasis among the conditions Ray Lin treats.

CMS data shows 374 Medicare services from Ray Lin across 11 procedure codes in 2024, for 154 Medicare patients. Medicare paid $32,145 for them. Every service was in an office.

CMS counts 154 Medicare patients who saw Ray Lin in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 57% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ray Lin's median patient age at 59, with 58% women.

In 2024, Ray Lin wrote 1,514 Medicare Part D claims for 520 patients. 95% of them were for generic drugs. CMS names the drug for 1,401 of them, across 19 drugs with 11 or more claims each, at $227,840 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Ray Lin for performance year 2024, reported as part of a group. Ray Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 208 general payments to Ray Lin from 18 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Dermavant Sciences, Inc. paid the most, $1,022.